Endocrine sequelae after treatment of pediatric cancer: From childhood to adulthood;Séquelles endocriniennes après traitement d'un cancer pédiatrique: De l'enfance à l'âge adulte

Bulletin du Cancer

Volumn 102, Issue 7-8, 2015, Pages 612-621

  Thomas Teinturier, Cécile ^a,b   Salenave, Sylvie ^a  

^a BICÊTRE HOSPITAL   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Childhood cancer; Endocrine sequelae; Growth hormone deficiency; Growth hormone therapy; Long term follow up; Radiotherapy

Indexed keywords

GROWTH HORMONE; FOLLITROPIN; LUTEINIZING HORMONE;

ADULTHOOD; BODY COMPOSITION; BODY HEIGHT; BONE DENSITY; BONE MASS; CANCER SURVIVOR; CANCER THERAPY; CARDIOVASCULAR RISK; CHILDHOOD CANCER; DISORDERS OF CARBOHYDRATE METABOLISM; ENDOCRINE DISEASE; ENDOCRINE SEQUELAE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEAN BODY WEIGHT; METABOLIC SYNDROME X; MORBIDITY; OBESITY; PARATHYROID DISEASE; PUBERTY DISORDERS; QUALITY OF LIFE; REVIEW; SECOND CANCER; THYROID DISEASE; ADOLESCENT; ADULT; AGE; BRAIN NEOPLASMS; CARDIOVASCULAR DISEASES; CHILD; DEFICIENCY; DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; FEMALE; HEAD AND NECK NEOPLASMS; MALE; NEOPLASMS; OSTEOPOROSIS; PUBERTY, PRECOCIOUS; RADIATION RESPONSE; RISK FACTOR; SURVIVOR; THYROID DISEASES; THYROID GLAND;

ADOLESCENT; ADULT; AGE FACTORS; BRAIN NEOPLASMS; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS; ENDOCRINE SYSTEM DISEASES; FEMALE; FOLLICLE STIMULATING HORMONE; GROWTH HORMONE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; MALE; METABOLIC SYNDROME X; NEOPLASMS; OSTEOPOROSIS; PUBERTY, PRECOCIOUS; RISK FACTORS; SURVIVORS; THYROID DISEASES; THYROID GLAND;

EID: 84937053865     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1016/j.bulcan.2015.03.013     Document Type: Review

References (31)

1. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87-94.
2. Sklar CA, Constine LS. Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 1995;31:1113-21.
3. Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA 2013;309:2371-81.
4. Brauner R, Rappaport R, Prevot C, Czernichow P, Zucker JM, Bataini P, et al. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. J Clin Endocrinol Metab 1989;68:346-51.
5. Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 1991;118:226-8.
6. Gurney JG, Ness KK, Stovall M, Wolden S, Punyko JA, Neglia JP, et al. Final height and body mass index among adult survivors of childhood brain cancer: Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2003;88:4731-9.
7. Ranke MB, Price DA, Lindberg A, Wilton P, Darendeliler F, Reiter E. Final height in children with medulloblastoma treated with growth hormone. Horm Res 2005;64:28-34.
8. Adan L, Sainte-Rose C, Souberbielle JC, Zucker JM, Kalifa C, Brauner R. Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation. Med Pediatr Oncol 2000;34:14-9.
9. Swerdlow AJ, Reddingius R, Spoudeas HA, Phipps K, Qiao Z, Ryder WDJ, et al. Growth hormone treatment of children with brain tumors and risk of tumor recurrence. J Clin Endocrinol Metab 2000;85:4444-9.
10. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87:3136-41.
11. Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 2006;91:3494-8.
12. Patterson BC, Chen Y, Sklar CA, Neglia J, Yasui Y, Mertens A, et al. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2014;99:2030-7.
13. Follin C, Thilén U, Osterberg K, Björk J, Erfurth EM. Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia. Pediatrics 2005;115:1613-22.
14. Lipshultz SE, Vlach SA, Lipsitz SR, Sallan SE, Schwartz ML, Colan SD. Cardiac changes associated with growth hormone therapy among children treated with anthracyclines. J Clin Endocrinol Metab 2010;95:3726-35.
15. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS, Muller J. Assessment of the hypothalamopituitary-adrenal axis in patients treated with radio-therapy and chemotherapy for childhood brain tumor. J Clin Endocrinol Metab 2003;88:3149-54.
16. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Poulsen HS, Muller J. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J Clin Endocrinol Metab 2003;88:136-40.
17. Quigley C, Cowell C, Jimenez M, Burger H, Kirk J, Bergin M, et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med 1989;321:143-51.
18. Chow EJ, Friedman DL, Yasui Y, Whitton JA, Stovall M, Robison LL, et al. Timing of menarche among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor study. Pediatr Blood Cancer 2008;50:854-8.
19. Armstrong GT, Whitton JA, Gajjar A, Kun LE, Chow EJ, Stovall M, et al. Abnormal timing of menarche in survivors of central nervous system tumors. Cancer 2009;115:2562-70.
20. Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement. J Clin Endocrinol Metab 2003;88:3682-9.
21. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, et al. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85:3227-32.
22. Haddy N, El-Fayech C, Guibout C, Adjadj E, Thomas-Teinturier C, Oberlin O, et al. Thyroid adenomas after solid cancer in childhood. Cancer Epidemiol Biomarkers Prev 2012;21:92-101.
23. Kovalchik SA, Ronckers CM, Veiga LH, Sigurdson AJ, Inskip PD, de Vathaire F, et al. Absolute risk prediction of second primary thyroid cancer among 5-year survivors of childhood cancer. J Clin Oncol 2013;31:119-27.
24. Vivanco M, Dalle JH, Alberti C, Lescoeur B, Yakouben K, Carel JC, et al. Malignant and benign thyroid nodules after total body irradiation preceding hematopoietic cell transplantation during childhood. Eur J Endocrinol 2012;167:225-33.
25. McMullen T, Bodie G, Gill A, Ihre-Lundgren C, Shun A, Bergin M, et al. Hyperparathyroidism after irradiation for childhood malignancy. Int J Radiat Oncol Biol Phys 2009;73:1164-8.
26. Teinturier C, Tournade MF, Caillat-Zucman S, Boitard C, Amoura Z, Bougneres PF, et al. Diabetes mellitus after abdominal radiation therapy. Lancet 1995;346:633-4.
27. De Vathaire F, El-Fayech C, Ben Ayed FF, Haddy N, Guibout C, Winter D, et al. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. Lancet Oncol 2012;13:1002-10.
28. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2003;21:1359-65.
29. de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, Gietema JA. The metabolic syndrome in cancer survivors. Lancet Oncol 2010;11:193-203.
30. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003;88:611-6.
31. Gurney JG, Kaste SC, Liu W, Srivastava DK, Chemaitilly W, Ness KK, et al. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 2014;61:1270-6.